The ReBoost Nasal Spray may contain mold and microbial contamination, while the ClearLife Allergy Nasal Spray may be linked ...

After a long run of regulatory stumbles and the recent wit | "Following the withdrawal of Ocaliva from the U.S. market, we ...

The firings come one month after the company voluntarily pulled a drug from the market at the request of the Food and Drug ...

Pfizer, which makes the shot, is fighting a lawsuit from more than 1,000 women who claim the company knew about the risk of meningiomas but failed to warn patients. Meanwhile, former Vice President ...

U.S. health agencies led by Health and Human Services Secretary Robert F. Kennedy Jr., were beset by multiple controversies ...

Aldeyra submitted the single successful trial to the FDA over the summer and the agency accepted the resubmitted NDA for ...

Geron Corporation, a Bay Area biotech company that's ramping up sales of its first commercial drug, announced on Thursday ...

Throughout President Trump’s second term, the Administration has aggressively abused its authority over federal personnel to ...

The medtech job market faces major shifts in 2026 due to federal layoffs, AI adoption, and M&A activity. Versatile skills ...

As recession fears intensify and layoffs mount, workers are seeking careers offering greater economic stability.

Collaborative discussions” with the FDA encouraged Praxis to submit early next year an approval filing for its epilepsy drug. Elsewhere, Rezolute shares plunged and Centessa announced a new CEO.

The ranks of U.S. government statisticians have been gutted in the past year due to layoffs and buyouts. That along with ...